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Abstract 
Addition of proteolytically generated fibronectin fragments (Fn-f) to cultured cartilage tissue causes greatly enhanced release of 
metalloproteinases (MMPs), such as pro-stromelysin-1 (proSln-1), and suppression of proteoglycan (PG) synthesis, through release of 
catabolic ytokines, while native fibronectin is ineffective. We have investigated whether enhanced release of proSln-1 was due to 
up-regulation of pro-Sin-1 mRNA. We report hat the addition of a 29-kDa (amino-terminal heparin-binding Fn-f) or a 140-kDa (central 
cell-binding Fn-f) to bovine chondrocytes in monolayer culture causes a dose dependent increase in the expression of pro-Sin-1 mRNA 
and the greatly enhanced release of pro-Sin-1 protein into the culture media. Up to 700 nM pro-Sin-1 was found in the conditioned media 
and metabolic labeling showed that it constituted a major portion of newly synthesized protein. A potential activator of pro-Sin-l, 
urokinase (u-PA), was released at elevated levels in the presence of the Fn-f while other activators, tissue plasminogen activator (t-PA) 
and plasmin activities were not detected. Addition of these activators to conditioned media did not allow conversion of pro-Sin-1 to active 
Sln-1. However, aminophenyl mercuric acid activated pro-Sln-1 to a 48-kDa Sin-1 form capable of degrading PG when added to cartilage 
suspensions. Gelatinase A mRNA was also enhanced, suggesting that the Fn-f may induce MMPs in general. However, the major 
regulator of Sln-1 activity, tissue inhibitor of MMPs form 1 (TIMP-1), was not induced at the gene level. Thus, a major effect of Fn-f on 
chondrocytes is to up-regulate pro-Sin-1 expression at the gene level, resulting in pro-Sin-1 as a major protein product. 
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1. Introduction 
Specific proteolytic fragments of the extracellular ma- 
trix protein, fibronectin (Fn-f), including an amino-termi- 
nal 29-kDa, a 50-kDa gelatin-binding and a 140-kDa cell- 
binding Fn-f, very potently cause chondrocytic chondroly- 
sis in vitro [1]. This is observed as a very rapid decrease in 
proteoglycan (PG) content of cultured cartilage during the 
first week in culture [2] and is associated with a marked 
elevation of metalloproteinases (MMPs) and temporary 
suppression of PG synthesis [1,3]. This observation is 
relevant to osteoarthritis and rheumatoid arthritis, since 
Abbreviations: Fn, fibronectin; Fn-f, fibronectin fragments; pro-Sin-l, 
pro-stromelysin-1; pro-Sin-I, stromelysin-1; PG, proteoglycan; AMPA, 
aminophenylmercuric acid; TIMP-1, tissue inhibitor of metallopro- 
teinases, form 1; DMEM, Dulbecco's modified Eagle's medium; DMB, 
dimethylmethylene blue; t-PA, tissue plasminogen activator; u-PA, uri- 
nary plasminogen activator 
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high concentrations of Fn-f of 29-kDa to 200-kDa are 
found in synovial fluids of patients with osteoarthritis and 
rheumatoid arthritis [4-8]. The relevance is also supported 
by our demonstration that injection of Fn-f into rabbit knee 
joints also leads to severe cartilage PG depletion within a 
few days [9]. 
The mode of action involves binding of Fn-f to the 
superficial surface of cartilage, as well as localization to 
the pericellular matrices surrounding chondrocytes [10]. 
The cellular targets may include a fibronectin (Fn) recep- 
tor, based on the observations that antibodies to the 
alphasbeta I integrin receptor suppress PG synthesis and 
release of stromelysin-1 (Sin-l) as do the Fn-f (unpub- 
lished) and analog peptides corresponding to the binding 
sequence in Fn for this receptor block activities of the Fn-f 
[10]. Subsequent up-regulation of specific genes and de 
novo synthesis of specific proteins appear to be involved 
and required, since the activities of the Fn-f are blocked by 
actinomycin D, cycloheximide and deoxyglucose [1]. Part 
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of the gene up-regulation appears to involve cytokines, 
which are known to induce proSln-1 and suppress PG 
synthesis [12,13], since greatly elevated levels of TNF-a, 
IL-1 and IL-6 are found in conditioned media of Fn-f 
treated cartilage cultures ([14]; Homandberg et al., data not 
shown) and neutralizing antibodies to these cytokines up- 
press Fn-f mediated Sin-1 release and reverse PG synthesis 
suppression [14]. 
Since we have found that antibodies to Sln-1 (MMP-3) 
suppress Fn-f mediated PG degradation [15], we have 
deduced that Sln-1 plays a major role in Fn-f mediated 
cartilage chondrolysis. However, there is no evidence that 
the Fn-f enhance gene expression of pro-Sin-1 as opposed 
to merely enhancing release of stored forms from cartilage 
tissue. Further, there is no information as to whether other 
MMPs are induced or whether a potential regulator of 
MMPs, such as TIMP-1, the tissue inhibitor of MMPs, is 
also induced or whether potential activators of MMPs, 
such as urinary plasminogen activator (u-PA), tissue plas- 
minogen activator (t-PA) or plasmin, were also up-regu- 
lated. Since our earlier work has focused only on protein 
and activity assays of MMPs [15], the data presented here 
show the first characterization f Fn-f induced release of 
Sln-1 from a bovine chondrocyte monolayer system at 
both the protein and mRNA level and provide evidence 
that Fn-f up-regulate gene expression of MMPs. 
2. Materials and methods 
All common laboratory chemicals were from Sigma (St. 
Louis, MO, USA), except where otherwise noted. Recom- 
binant human pro-Sin-1 and the polyclonal anti-sera to 
human pro-Sin-1 were gifts from Dr. Michael Lark (Merck, 
Sharpe and Dohme, Rahway, NJ, USA). The 1.8-kb cDNA 
probe for rabbit pro-Sin-1 was a generous gift from Dr. 
Constance Brinckerhoff (Dartmouth Medical School, Dart- 
mouth, MA, USA). A 3.9-kb genomic DNA clone for 
human TIMP-I, designated TIMP-3.9X (ATCC #59666) 
and a 1.117-kb cDNA clone for human type IV collage- 
nase (gelatinase A), designated pH3a (ATCC #79064), 
were purchased from ATTC (Rockville, MD, USA). 
2.1. Isolation of Fn-f 
The Fn-f studied were the 140-kDa central cell-binding 
Fn-f and the 29-kDa amino-terminal heparin-binding Fn-f 
and were generated and treated for cell culturing as de- 
scribed [2,16]. 
2.2. Isolation of chondrocytes for monolayer cultures 
Articular cartilage was removed aseptically from the 
metacarpophalangeal joints of 18-20-month-old bovines. 
Chondrocytes were isolated using a modification of the 
technique of Kuettner et al. [17] for preparation of a high 
density chondrocyte culture system. Briefly, the cartilage 
tissue was subjected to a 90-min pronase (Calbiochem, San 
Diego, CA, USA) digestion followed by an 18-h collage- 
nase P (Boehringer Mannheim, Indianapolis, IN) digestion 
in DMEM/5% FBS. The resulting cell suspension was 
washed repeatedly, cell counted and the cells were plated 
at 21 million cells/100 mm dish or 0.75 million cells/well 
in a 24-well plate in DMEM/10% FBS. The media were 
changed every other day and serum-free cultures were 
started on day 3 by washing with 8 to 10 volumes of 
DMEM overnight. 
2.3. Casein and gelatin zymography 
Conditioned media from cultures was collected, stored 
at 9°C without freezing and then dialyzed against 20 mM 
NaC1. The solution, without concentration, was then mixed 
3:1 with Laemmli sample buffer [18] and without prior 
boiling, the samples were loaded onto a 10% 
acrylamide/0.1% gelatin or 10% acrylamide/0.1% casein 
gel and zymography performed as described [19]. 
2.4. Western blot analysis 
Serum-free conditioned media was prepared for elec- 
trophoresis and blotting onto nitrocellulose as described 
[15]. The blotted filters were then incubated with a 1:250 
dilution of polyclonal rabbit anti-sera to human pro-Sin-I, 
washed, incubated with lZSI-protein G and exposed to 
X-ray film as described [15]. 
2.5. Pro-Sln-1 ELISA 
Serum free conditioned media (0.5 ml vol) were col- 
lected and assayed as described [15]. 
2.6. Metabolic labeling with [35S]methionine and cysteine 
Serum free cultures were treated with 20 /xCi of 
Tran 35 S-label (ICN, Irvine, CA, USA) at the same time as 
the addition of the Fn-f on days 1, 3 and 5 of the culture. 
After another 24 h of incubation, the conditioned media 
were collected, dialyzed against 20 mM NaC1, concen- 
trated 20-fold on a Speed-O-Vac concentrator without 
application of heat and subjected to SDS-PAGE on 10% 
gels. The gels were then treated with Enhance 
(Dupont/NEN, Boston, MA, USA) for fluorography ac- 
cording to the protocol supplied by the company. 
2.7. Assays for u-PA, t-PA and plasmin like activity 
Phenol red deficient DMEM (Sigma) was used for 
cultures to be assayed in order to avoid interference with 
the chromogenic assays. Cultures were established and 
adjusted to 10 nM or 0.1 /zM 29-kDa Fn-f and media 
collected at 1, 3 and 5 days after the addition of the Fn-f. 
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To 1 ml volumes of the conditioned media, 10 /xl aliquots 
of a 10 mg/ml  solution of S-2444 (pyro-Glu-Gly-Arg- 
paranitroanilide), or 10 /xl of Chromazym t-PA (prepared 
as directed by supplier: Boehringer-Mannheim, Indianapo- 
lis, IN, USA) or 10 /~1 of a 10 mg/ml  solution of S-2251 
(H-D-Val-Leu-Lys-paranitroanil ide) w re added, respec- 
tively, to detect he presence of u-PA, t-PA or plasmin-like 
activities as described [15,20]. The solutions were incu- 
bated for 2 weeks at 37°C. For controls, media from 
cultures to which no Fn-f were added were also assayed. 
For additional controls, incubations of substrate without 
added media were assayed and the amount of hydrolysis 
subtracted from all other assays. Standard curves were 
established using known amounts of each proteinase. The 
limit of detection was about 0.1 ng /ml  with a linear range 
from 0.1 ng /ml  to 100 ng /ml  for each proteinase. 
2.8. Quantification 03" Sln-1 mediated PG release from 
metabolically inactive bovine cartilage 
To prepare cartilage tissue substrate for testing prote- 
olytic activity, test cartilage was first rendered metaboli- 
cally inactive by incubation of cartilage with 20 /zM 
deoxyglucose, 20 /xM actinomycin D and 40 /xg /ml  
cycloheximide in DMEM for 48 h at 22°C, followed by 
three f reeze/thaw cycles. Serum-free media from chondro- 
cytes treated with 10 nM 29-kDa Fn-f in DMEM for 24 h 
were then added to the treated bovine articular cartilage 
slices in a final volume of 1 ml DMEM at 37°C. Aliquots 
of the supernatant were then collected 1 and 3 days later 
and analyzed for PG content using the DMB assay de- 
scribed by Chandrasekhar et al. [21]. The ~g of PG in the 
media were then related to the mass of the cartilage in the 
1 ml incubation. The final quantification was based on a 
mean and SD of at least three cartilage samples. 
2.8.1. Northern blot analysis 
Total RNA was isolated from control and Fn-f treated 
serum-free DMEM cultures on days 1, 3 and 5 after the 
addition of various concentrations of the 29-kDa Fn-f or 
140-kDa Fn-f or BSA using a modification of the guani- 
dine isothiocyanate/acid phenol extraction method of 
Chomzynski and Sacchi [22]. Total RNA (30 /zg) from 
each group was subjected to denaturing agarose gel elec- 
trophoresis and transferred to a charged nylon membrane 
[23] (GeneScreen Plus, Dupont/NEN).  Radioactively la- 
beled probes were prepared with [32p]dCTP utilizing the 
random primed DNA labeling system and protocol sup- 
plied by the manufacturer (Boehringer-Mannheim), result- 
ing in a final specific activity of about 6000 C i /mmol  
(Amersham, Arlington Heights, IL, USA). Membranes 
were then hybridized at 43°C overnight, washed stringently 
and exposed to X-ray film [23] (X-Omat, Kodak, Rochester, 
NY, USA). The bands on the X-ray film were quantified 
by laser densitometry using an LKB model 2202 Ultrascan 
laser gel densitometer controlled by a Hoefer Scientific 
Instruments data system GS-365-W interface card. Peak 
areas were calculated using Hoefer data system software. 
3. Results 
3.1. A 57-kDa proteinase with caseinolytic activity was 
detected in 29-kDa Fn-f treated cultures 
We attempted to determine whether Sln-1, as well as 
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Fig. 1. Identification of proteinase activity in bovine chondrocyte cultures incubated with the 29-kDa Fn-f as shown by casein zymography. Conditioned 
media from serum free cultures were collected 24 hours after the addition of the 29-kDa Fn-f, dialyzed, concentrated 10 X and subjected to zymography 
using a 10 /xl volume of concentrate. Panel A shows a band of caseinolytic activity which was decreased in size after activation with APMA. Lane M 
contains molecular weight standards. The 68-kDa albumin standard oes not stain on zymograms. Lane 1 is 10 nM 29-kDa Fn-f conditioned media 
collected from cultures at day 1; lane 2 is the same media incubated with 0.2 mM APMA. The position of the 57-kDa pro-Sin-1 band is denoted by the 
large arrow and the 48-kDa activation product is denoted by a small arrow on the right hand side of the gel. Panel B shows the effects on increasing 
concentrations of the 29-kDa Fn-f. M denotes molecular weight standards and S denotes 200 ng of recombinant human pro-Sin-1. Note that he pro-Sin-1 
standard which has been determined tobe 57 kDa on SDS acrylamide gels migrates with a size similar to that of 68-kDa albumin. Lane 1 is control 
conditioned media, lanes 2 to 5 are conditioned media concentrates from cultures adjusted to 1, 10, 100 nM and 1 /~M 29-kDa Fn-f, respectively. The 
57-kDa pro-Sin-1 band is denoted by the large arrow and the 48-kDa active Sln-1 form is denoted by the small arrow on the right-hand side of the gel. 
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chondrocytes, by a highly potent amino-terminal 
thrombin-generated 29-kDa Fn-f as described [1]. Serum- 
free conditions were used to avoid addition of serum-de- 
rived proteinases to the cultures. Chondrocyte cultures in 
DMEM were adjusted to 10 nM 29-kDa Fn-f for 24 h. The 
media were then recovered and subjected to zymography 
on casein gels. Since SDS can activate zymogens [24], 
both zymogens and active proteinases could be visualized. 
Fig. 1A shows a casein zymogram of conditioned media 
from these cultures and of conditioned media subsequently 
adjusted to 0.2 mM aminophenyl mercuric acid (APMA) 
for 8 h at 22°C, in order to activate any zymogens present. 
The Fn-f treated media (lane 1) contained a 57-kDa pro- 
teinase with a faint 48-kDa band. Treatment of the same 
media with APMA converted the proteinase (marked with 
a large arrow) into a smaller form (small arrow), suggest- 
ing that the larger proteinase was a zymogen. The 20-kDa 
band near the bottom of the gel is likely a small Sln-1 
form which was also observed in Fn-f treated cartilage 
cultures [15]. 
Fig. 1B shows a casein zymogram of media from 
cultures treated with various concentrations of the 29-kDa 
Fn-f. The M lane corresponds to size standards. The S lane 
corresponds to a 57-kDa human pro-Sin-1 standard and in 
this particular gel shows light bands of 57, 48 and 30 kDa. 
The expected position of the 57-kDa and 48-kDa forms are 
marked with a large and small arrow, respectively. The 
control media in lane 1 shows that proteinases were not 
enhanced in cultures not treated with the Fn-f. However, 
very light bands could be observed in cultures treated with 
1 nM 29-kDa Fn-f (lane 2). At 10 nM Fn-f (lane 3) very 
obvious proteinase bands are observed which co-migrated 
with the 57-kDa pro-Sin-1 and 48-kDa active Sln-1 forms. 
With 100 (lane 4) and 1 /zM Fn-f (lane 5), the relative 
amount of the 57-kDa zymogen decreased and the amount 
of active 48-kDa increased. Since Sin-1 is the major 
chondrocyte derived proteinase active on casein, the size 
of the detected forms strongly suggested that these bands 
were due to pro-Sin-1 and Sln-1. Gelatin zymography 
(data not shown) showed that the Fn-f from 1 nM to 1 p~M 
caused the additional appearance of bands of about 72 kDa 
and 98 kDa, likely due to gelatinases A and B, respec- 
tively, which are known to be synthesized by chondrocytes 
[25]. The 57-kDa bands were much lighter in this gelatin 
gel than those of the 72-kDa and 98-kDa gelatinases and 
there was a pattern consistent with conversion of 57-kDa 
bands to 48-kDa bands as the Fn-f concentration was 
increased. 
3.2. The 57-kDa proteinase reacted with antibodies to 
pro-Sin-1 as shown by Western blot analysis 
Western blotting was used to confirm that the 57-kDa 
proteinase was pro-Sin-1. Serum-free media for cultures 
with both the 29-kDa Fn-f and a 140-kDa Fn-f, which 
contains the receptor-binding domain of Fn which is also 
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Fig. 2. Analysis of conditioned media by Western blotting with anti-sera 
to human pro-Sln-l-Chondrocyte cultures in serum-free DMEM were 
adjusted to 100 nM 140-kDa Fn-f or 100 nM 29-kDa Fn-f and at days 1, 
2 and 3 the media were collected, dialyzed, concentrated and subjected to 
Western blotting with human pro-Sin-1 anti-sera, followed by reaction 
with 125I-protein G for subsequent fluorography. Panels A, B and C show 
media from control, 100 nM 140-kDa Fn-f and 100 nM 29-kDa Fn-f 
treated cultures, respectively. S corresponds to a human pro-Sin-1 stan- 
dard (0.1 /xg). 
Fig. 2A is a blot from control cultures without added 
Fn-f. Lane S shows a pro-Sln-I standard of 57 kDa which 
contains maller forms of 43 kDa and 30 kDa, denoted by 
the arrows. These forms are not present in control samples 
at days 1, 2 and 3. Fig. 2B shows a blot of media from 
cultures adjusted to 100 nM 140-kDa Fn-f for days 1, 2 
and 3. Strongly reactive bands are observed at days 1, 2 
and 3 and a peak of pro-Sin-1 is suggested at day 2. Fig. 
2C shows a blot of cultures adjusted to 100 nM 29-kDa 
Fn-f for days 1, 2 and 3. The intensities of the bands are 
greater than in the 140-kDa Fn-f treated cultures and a 
peak at day 2 is also suggested. The lack of detection of 
48-kDa forms on the Western blot, in contrast to the casein 
zymogram in Fig. 1, could be due to the greater sensitivity 
of the casein zymogram to the small Sin-1 forms. It is also 
possible that this 48-kDa form detected on zymograms, but 
not detected by Western blotting, is not a Sin-1 form but 
rather another type of proteinase. However, since the 
48-kDa proteinase was not detected on dye stained gels as 
will be shown, this form is not present at significant levels. 
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3.3. The release of pro-Sin-1 into conditioned media was 
dependent on Fn-f concentration as shown by ELISA 
An ELISA method [15] was used to quantify the rela- 
tive increase in pro-Sin-1 protein released into the media 
of Fn-f cultured cartilage, however since only human 
pro-Sin-1 was available as a standard, only fold increases 
and not absolute amounts of pro-Sin-1 are reported. Table 
1 shows that BSA (100 nM) treated tissue releases pro- 
Sln-1 at control levels or lower. However, 1 nM 140-kDa 
Fn-f treatment enhanced release to 8-fold over control 
levels by day 5, while 10 nM Fn-f enhanced to this level 
earlier, by day 3. However, 100 nM 140-kDa Fn-f was half 
as effective as 10 nM and caused an even earlier peak, at 
day 1. The 1 /zM concentration actually suppressed release 
to one-third of control levels. 
The 29-kDa Fn-f also caused about the same concentra- 
tion dependent relative increases in release which appeared 
to peak earlier with increasing concentration of Fn-f. Table 
1 shows that 1 nM Fn-f only doubled release over control 
levels with a peak at day 5, while 10 nM caused a 12-fold 
increase with a peak at day 3. This 12-fold increase can be 
compared with the 8-fold effect of the 140-kDa Fn-f. A 
concentration of 100 nM 29-kDa Fn-f caused a 3.6-fold 
increase with an apparent peak at day 3. Thus, 1 /zM 
29-kDa Fn-f was not as suppressive as 1 /zM 140-kDa 
Fn-f. Collectively, these data suggest hat the 29-kDa Fn-f 
is more effective than the 140-kDa Fn-f and that for both, 
increasing the concentration from 1 to 100 nM causes the 
peak of release to occur earlier, that the maximal effect of 
either Fn-f on protein release occurred at 10 nM in cell 
culture and that 1 /xM of either Fn-f is either suppressive 
or sub-optimal. The suppression may be due to suppression 
of general protein synthesis by higher concentrations of 
Fn-f as reported [2,3,11 ]. 
3.4. The 57-kDa pro-Sin-1 form was the major metaboli- 
cally labeled product released into the media following 
stimulation with the Fn-f 
Chondrocyte cultures in DMEM containing Fn-f were 
metabolically labeled with 35S methionine/cysteine to de- 
termine whether pro-Sin-1 represented a major de novo 
synthesized product. A concentration of 100 nM was tested 
here since this concentration appeared to be optimal for 
pro-Slln-1 release. Fig. 3 shows a fluorogram of the condi- 
tioned media. At day 1, the control cultures (Fig. 3A) show 
a 57-kDa pro-Sin-1 band (position denoted by arrow) with 
some higher molecular mass bands of 68 kDa and upward 
(immediately above the arrow). At days 3 and 5, proteins 
of too great a mass to enter the gel were labeled. However, 
at day 1, the media of the 29-kDa Fn-f treated cultures 
(Fig. 3B) showed much higher levels of the 57-kDa pro- 
tein, with the amounts decreasing by day 3. This trend is 
consistent with the data shown in Table 1 for cultures with 
the 100 nM 29-kDa Fn-f. Note that the 29-kDa Fn-f has 
enhanced synthesis by day 1 of higher molecular mass 
material, which could include complexes of pro-Sln-l .  
Nonetheless, the major de novo synthesized protein enter- 
ing the gel appears to correspond to the size of pro-Sin-1. 
3.5. The 57-kDa pro-Sin-1 protein was the major protein 
found in conditioned media 
To confirm the identity of the major de novo synthe- 
sized protein as pro-Sin-I ,  bovine chondrocyte cultures in 
DMEM containing 100 nM 29-kDa Fn-f were cultured for 
3 days and media collected. The resultant protein concen- 
tration as determined by the Bio-Rad assay of the concen- 
trate was about 840 /zg/ml .  Fig. 4A shows a gelatin 
zymogram of the concentrates. Gelatin was used instead of 
Table 1 
Effect of Fn-f on Pro-Sin-1 release from bovine chondrocytes in DMEM 
Condition Fold increase compared tocontrol values at respective days 
Day 1 Day 3 Day 5 
Control 1.0 (+) 0.31 a 1.0 (+) 0.36 1.0 (+) 0.08 
BSA (100 nM) 1.1 (+) 0.25 0.7 (+) 0.31 0.3 (+) 0.08 
1 nM 140-kDa 2.0 (_)  0.19 5.3 (+) 0.09 (s) 8.0 (_ )  0.1(s) 
10 nM 140-kDa 3.7 (+) 0.16 (s) 8.5 (+) 0.3 (s) 4.8 (+) 0.1(s) 
100 nM 140-kDa 4.2 (+) 0.9 (s) 3.0 (+) 0.66 1.0 (+) 0.19 
1 ,u,M 140-kDa 0.5 ( 5: ) 0.31 0.3 ( + ) 0.47 0.3 ( 5: ) 0.09 
1 nM 29-kDa 1.7 (+)0.07 2.0(+)0.35 6.1 (+) 0.1(s) 
10 nM 29-kDa 2.6 ( + ) 0.06 (s) 11.5 ( _ ) 0.25 (s) 4.7 ( + ) 0.2(s) 
100 nM 29-kDa 3.6 (+) 0.2 (s) 3.1 (+) 0.09(s) 2.1 (+) 0.3 
1 ~M 29-kDa 0.4 (+) 0.12 1.7 (+) 0.36 0.4 (+) 0.6 
Chondrocyte cultures in DMEM were treated with various concentrations of the 140-kDa Fn-f or with various concentrations of the 29-kDa Fn-f or with 
100 nM BSA. Conditioned media were collected at days 1, 3 and 5 after the addition of the Fn-f. Media (0.5 ml) were dialyzed against 20 mM NaCI, 
concentrated 20-fold and brought up to 200 /xl with 0.1 M sodium bicarbonate buffer (pH 9.5). The samples were then loaded into a 96-well plate and 
treated according to the published protocol [15]. Assays were performed in triplicate on all samples 
a The mean and SD value in parentheses are based on n = 3. s indicates ignificance, based on a P value of < 0.05 using the Student's t-test, as 
compared to the same day controls. 
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Fig. 3. Fluorogram of conditioned media from cultures exposed to Fn-f 
and [ 35 S]met/cys-Bovine chondrocyte cultures in DMEM were incubated 
with [35S]Translabel (70% methionine/30% cysteine) and without (A) or 
with (B) 100 nM 29-kDa Fn-f for 24 h at days 1, 3 and 5 after the 
addition of the Fn-f. The x-axis shows days in culture. Therefore, for 
example, the day 3 time-point corresponds to protein labeled between 
days 3 and 4 in culture with the Fn-f. The media were dialyzed, 
concentrated 20-fold, and subjected to electrophoresis on a 10% SDS- 
PAGE gel. The gel was then treated with Enhance and subjected to 
fluorography. The presence of a band corresponding to 57 kDa is denoted 
by a large arrow and the presence of a band corresponding to 48 kDa is 
denoted by a small arrow. 
casein, in order to show the presence of other gelatinases 
in the conditioned media and to illustrate that the 57-kDa 
caseinase identified in earlier data as pro-Sin-1 was rela- 
tively inactive as a gelatinase. Lane S shows molecular 
weight standards and lanes 1, 2 and 3, the effect of 
increasing amounts of concentrated media. All the lanes 
show the presence of the 72-kDa and 98-kDa gelatinases, 
while lane 3 with the highest volume of media, shows the 
additional presence of a light 57-kDa proteinase (denoted 
by arrow) and some diffuse banding at 60-65 kDa. Com- 
parison with Fig. 1 confirms that the 57-kDa pro-Sin- 1 was 
more active on casein than on gelatin and that the 72-kDa 
and 98-kDa gelatinases detected in Fig. 4A were not very 
active as caseinases or general proteinases. 
Similar samples were subjected to electrophoresis and 
the gel stained with Coomassie blue. Fig. 4B shows in lane 
1, a concentrate from Fn-f treated cultures. An intense 
band at about 57 kDa and a very light band at about 70 
kDa are also observed. Lanes 2 and 3 shows a non-reduced 
sample and a reduced sample from control cultures, respec- 
tively. Lane 4 shows the effect of subjecting the Fn-f 
treated media to disulfide reduction in the presence of 0.1 
M dithiothreitol. Note that the apparent molecular mass 
has now increased to about 72 kDa, likely due to the effect 
of reduction on increasing the radius of the denatured 
protein. It should be noted that the assignment of pro-Sin-1 
as 57-kDa has been based on a non-reduced molecular 
mass as seen on a zymogram for all the data presented 
herein. 
Another gel was subjected to Western blot analysis. Fig. 
4C shows that the reduced protein reacted with anti-sera to 
pro-Sin-1. Activated 48-kDa Sln-1 was not detected on this 
stained gel or on the Western blot. Therefore, these data 
collectively show that pro-Sin-1 was the major protein 
made by chondrocytes in serum-free cultures stimulated 
with Fn-f. Because pro-Sln-I is the major protein and the 
A B C 
S 1 2 3 S 1 2 3 4 S 1 2 
Fig. 4. Characterization of protein found in conditioned media by zymography, SDS-PAGE and Western blot analysis. Bovine chondrocyte cultures in 
DMEM were adjusted to 100 nM 29-kDa Fn-f. After 3 days, conditioned media were dialyzed against 20 mM NaC1, 50 mM Tris buffer, pH 7.4, and 
concentrated 20 X and subjected to analysis. Panel A is a zymogram. Lanes 1 to 3 are conditioned media containing 0.4, 1.2 and 4 /xg of protein, 
respectively, or 1, 3 or 10/zl of concentrated media. The position of 48 kDa is marked by an arrow on the left hand side. Panel B is a 10% SDS-PAGE gel 
stained with Coomassie. Lane 1 is a 4/xg quantity of protein from the 20 X concentrated Fn-f conditioned media and lane 4 is the same quantity subjected 
to reduction with 0.1 M dithiothreitol. Lanes 2 and 3 are the same volumes as in lanes 1 and 4 of unreduced and reduced media from control cultures. 
Panel C is a Western blot of 20 x concentrated conditioned media reacted with anti-sera to human pro-Sin-1. The lanes are each of 4/xg of protein from 
the 20 X concentrate of Fn-f conditioned media. Mol wt. standards are denoted by S in the left lane. 
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protein assay data showed a protein concentration of 840 
/zg/ml for the 20 X concentrate, the concentration of 
pro-Sin-1 in the conditioned media after 3 days can be 
estimated as about 700 nM. 
3.6. The 57-kDa pro-Sin-1 form from Fn-f treated bovine 
chondrocytes was not actiuatable to the active 48-kDa 
form with human u-PA, t-PA and plasmin 
Potential activators of MMP zymogens [26-29] were 
assayed in Fn-f conditioned media. Bovine chondrocyte 
cultures were incubated in phenol red-deficient DMEM 
containing 100 nM 29-kDa Fn-f in order to decrease 
interference in the chromogenic assay. The assays did not 
show detectable levels of plasmin like activity (S-2251 
cleavage) or t-PA like activity in either control or Fn-f 
conditioned media However, u-PA like activity (S-2444 
cleavage) was detected. Control samples showed levels 
less than 1 ng/ml  (___) 0.2 (n = 3) by day 1, 3 or 5 in 
culture, while the 100 nM 29-kDa Fn-f treated cultures 
showed maximal release of 103 ng/ml  (+)  11 (n = 3) at 
day 1 and levels about 20% lower by days 3 and 5. Thus, 
release of t-PA or plasmin was not apparently enhanced by 
the Fn-f to detectable levels, however the Fn-f enhanced 
release of u-PA like activity by 100-fold. 
We then investigated whether u-PA, t-PA or plasmin at 
concentrations of 1, 10 or 100 ng/ml  could activate 
bovine pro-Sln-I in Fn-f conditioned media. The condi- 
tioned media were incubated with each activator for peri- 
ods of 1, 3 and 7 days at 22°C in DMEM. Casein 
Table 2 
Effect of 29-kDa Fn-f conditioned media on 
cally inactive cartilage 
PG release from metaboli- 
Condition /xg PG/mg cartilage 
(_+) S.D. (P value) a 
Cartilage suspension 
Fn-f solution 
Media from controls at day 1 
Media from controls at day 1 + APMA 
Media from Fn-f treatment a day 1 
Media from Fn-f treatment a day 1 + APMA 
1.4(+)0.3 
1.4(+)0.2 
1.5 (+)  0.4 
1.6(+)0.3 
1.4(+)0.5 
4.1 (__+) 0.9 (P = 0.005) 
Test cartilage was first rendered metabolically inactive to prevent up-reg- 
ulation of Sln-I protein as described in Section 2. 
Conditioned media from bovine chondrocytes incubated with 100 nM 
29-kDa Fn-f in DMEM for 24 h were then added to the treated bovine 
articular cartilage slices in a final volume of 1 nd DMEM at 37°C and 
aliquots of the supernatant were then collected 1 and 3 days later and 
analyzed for PG content using the DMB assay. The /xg of PG were then 
related to the mass of the cartilage in the 1 ml incubation 
a p values were based on one sided Student's t-test with n = 3 and where 
a P < 0.05 was considered significant. Values for Fn-f media with or 
without APMA were compared to control media without APMA. Only 
those values found to be significantly different are shown with a numeri- 
cal P value. 
zymography was performed in order to test for decreases 
in mass of the treated pro-Sln-l. Neither decreases in mass 
of the pro-Sin-1 nor decreases in intensities of the 57-kDa 
band occurred at any of the concentrations for any of the 
time periods tested (data not shown). 
140 , 29 -1  J-'2"q~"ID-I I I ! C°nt~l  I " 'BS~ ! I l r 29-100 
2.0 kb-  
1 3 5 1 3 5 1 3  5 1 35  1 3 5 1  3 5 
Days 
Fig. 5. Northern blot for pro-Sln-I mRNA for cultures exposed to various concentrations of Fn-f for 1, 3 and 5 days. Northern blot of total RNA was 
performed on cultures at 1, 3 and 5 days after addition of the Fn-f. Cultures to which nothing was added or which were adjusted to 100 nM BSA were used 
as controls. Total RNA was isolated at days indicated and an aliquot of 25 /xg of total RNA was loaded in each lane and subjected to electrophoresis ona 
denaturing agarose gel. The gel was then blotted onto nylon and hybridized to [32p]dCTP-labeled cDNA for rabbit pro-Sin-l, washed stringently and 
exposed to X-ray film overnight. From left to right are control cultures (no treatment), cultures adjusted to 1 /xM BSA, or 100 nM 140-kDa Fn-f, or 1 nM 
29-kDa Fn-f, or 10 nM 29-kDa Fn-f or 100 nM 29-kDa Fn-f. Days are at the bottom of the figure. The pro-Sin-1 mRNA is denoted with the 2.0-kb marker. 
The bottom shows the gel stained with ethidium bromide prior to the blotting and shows the even loading of the total RNA. 
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3.7. The pro-Sin-1 form could be activated with APMA to 
a form capable of degrading and releasing PG when 
added to cartilage suspensions 
The ability of the pro-Sin-1 to be activated to a form 
capable of degrading PG from cartilage made metaboli- 
cally inactive was investigated as described in Section 2. 
Table 2 shows that the passive release of PG from a 
cartilage suspension in DMEM occurred at the level of 1.4 
/zg PG/mg cartilage. Addition of 100 nM Fn-f to the 
inactive cartilage did not enhance release of PG, suggest- 
ing that the tissue was indeed inactive and that the Fn-f 
solution did not contain contaminating proteinases. Media 
from tissue not cultured with Fn-f which were assayed 
both with and without prior activation with AMPA did not 
enhance release of PG. Media from Fn-f treated cultures 
that was not treated with APMA did not show enhanced 
activity; however, addition of APMA greatly increased 
release of PG. Therefore, the pro-Sin-1 in the Fn-f condi- 
tioned media was activatable to an active form. Other 
experiments hown earlier (Fig. 1) confirmed that this 
form was 48 kDa. 
3.8. The enhanced release of the pro-Sin-1 form was due 
to a time- and dose-dependent increase in mRNA for 
pro-Sin-1 in bovine chondrocytes as shown by Northern 
blot analysis 
Total RNA was isolated from chondrocytes at various 
times after addition of the 29-kDa and 140-kDa Fn-f, 
Northern blotting performed and blots probed with ra- 
dioactively labeled rabbit pro-Sin-1 cDNA as described in 
Methods. Initial slot blot analysis of total RNA showed 
expression of mRNA for pro-Sin-1 as early as 4 h after the 
addition of the Fn-f (data not shown). Total RNA was then 
subjected to Northern blot analysis as shown in Fig. 5 
(upper) which shows that control cultures and 100 nM 
BSA treated cultures express pro-Sin-1 mRNA at measur- 
able levels as observed as a 1.8-2.0 kb band that strongly 
hybridized with the radioactively labeled probe. The band 
is the same size as that reported previously by Fini et al. 
[30] for pro-Sin-1 mRNA. Treatment with 100 nM of the 
140-kDa Fn-f greatly enhanced levels by days 1, 3 or 5. 
Treatment with 1, 10 and 100 nM 29-kDa Fn-f caused 
progressively faster increases in mRNA. However, 100 nM 
of either Fn-f caused a greater induction than lower con- 
Table 3 
Peak integration ofbands from stromelysin-1 Northern blot 
Condition Fold increase compared tocontrol 
values at respective days 
Day 1 Day 3 Day 5 
100 nM BSA 1.8 0.3 1.1 
100 nM 140-kDa 4.2 2.0 1.8 
1 nM 29-kDa 1.1 1.0 3.6 
10 nM 29-kDa 2.8 4.4 2.5 
100 nM 29-kDa 5.3 2.1 2.4 
Lanes from the Northern blot in Fig. 5 were scanned using an LKB model 
2202 Ultrascan laser gel densitometer controlled by a Hoefer Scientific 
Instruments data system GS-365-W interface card. Peak areas were 
calculated using Hoefer data system software. A membrane with bands of 
various intensities was used to verify that the bands from the Northern 
blot fell within the linear ange of quantitation. 
centrations, in contrast o the protein ELISA data in Table 
1. This difference might be due to proteolytic processing 
of pro-Sln-I to forms incapable of reacting to anti-sera. 
Note that the effect of the 100 nM 29-kDa Fn-f appears to 
be more potent than 100 nM 140-kDa Fn-f as also sug- 
gested by the protein data in Table 1. Fig. 5 (bottom) 
shows the gel stained with ethidium bromide prior to the 
blotting and demonstrates the even loading of the total 
RNA. 
The fold increases were quantified by laser densitom- 
etry as summarized in Table 3. For 100 nM of either Fn-f, 
the peak was at day 1 and the timing of the peak was 
delayed as the concentration was decreased, consistent 
with the protein data shown in Table 1. The magnitude of 
these maximal fold increases in mRNA of 4- to 5-fold can 
be compared with the fold increases in protein of 8- to 
11.5-fold shown in Table 1. 
3.9. The 29-kDa and 140-kDa Fn-f also up-regulated the 
gelatinase A gene in a dose and time dependent fashion as 
shown by Northern blot analysis 
In order to determine whether there was a more general 
effect on MMPs, the blot used in Fig. 5 was stripped and 
re-probed with a pH3a probe for human gelatinase A 
obtained form ATCC (#79064). This probe hybridizes to 
the mRNA coding for the amino-terminal portion of hu- 
man gelatinase A and has been used to identify the mRNA 
for gelatinase A as a 3.1 kb band [31]. Fig. 6 shows that 
while the control and BSA treated cultures showed rela- 
rc-  r -I J w2 --tq 
+ ,_ , , , ,  . . . . . . . . .  . . . . . . . . .  
1 3 5 1 3 5 1 3 5 1 3 5 1 3 5 1 3 5 
Days 
Fig. 6, Northern blot for gelatinase A mRNA for cultures exposed to various concentrations of Fn-f for 1, 3 and 5 days - The blot is the same as used in 
Fig. 5 after stripping the pro-Sin-1 probe by boiling the blot in 0.1 × SSC/I% SDS for 30 min. The Lanes are the same as shown in Fig. 5 with 
experimental groups on top and days on the bottom. The gelatinase A mRNA is shown as a 3.1-kb band, 
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Fig. 7. Northern blot for TIMP-I mRNA for cultures exposed to various concentrations of Fn-f for 1, 3 and 5 days. The Northern blot in Fig. 6 was 
stripped of probe by boiling in 0.1% SSC/I% SDS for 30 min, and checked to ensure total removal of the probe. The blot was then probed with 
32 P-labeled cDNA for human TIMP-1, washed stringently and exposed to X-ray film. The lanes are the same as shown in Fig. 6 with experimental groups 
on top and days on the bottom. The TIMP-I mRNA is denoted by the 0.9-kb marker. 
tively low mRNA levels at days 1, 3 or 5, treatment with 
100 nM 140-kDa or 1 to 100 nM 29-kDa Fn-f greatly 
up-regulated the gelatinase A mRNA. 
3.10. TIMP-1 mRNA expression was not altered by the 
addition of  the Fn-f  
The same blot as used in Figs. 5 and 6 was stripped and 
re-probed with a cDNA probe for human TIMP-1 (desig- 
nated TIMP-3.9X by ATCC) which has been described 
[32]. Fig. 7 shows that while control and BSA treated cells 
did express mRNA for TIMP-1, the addition of the 140-kDa 
or 29-kDa Fn-f did not greatly up-regulate the TIMP-1 
mRNA which appears as a 0.9-kb band, the same size as 
reported elsewhere [32]. 
4. D iscuss ion  
This work is novel in that the data suggest that in 
Fn-f-mediated cartilage chondrolysis as caused by greatly 
enhanced MMP activities, the enhancement of MMP activ- 
ities likely occurs by greatly enhanced gene expression. 
This conclusion was supported by several observations. 
Analysis of conditioned media from Fn-f treated chondro- 
cyte cultures by zymography showed the dose dependent 
release of a 57-kDa proteinase which was more active on 
casein than on gelatin. Western blot analysis confirmed 
that the band was pro-Sin-1. ELISA analysis confirmed 
that pro-Sin-1 was released in a dose dependent fashion, 
while labeling experiments howed that pro-Sin-1 repre- 
sented a major protein synthesized in chondrocytes incu- 
bated with Fn-f. Quantification showed that pro-Sin-1 was 
released at very high levels of about 700 nM with a three 
day culture incubation. 
In studies of the effects of varying concentrations of 
Fn-f on the kinetics of pro-Sin-1 expression, it was ob- 
served by analysis of protein and mRNA levels for pro- 
Sln-1 that with lower concentrations of Fn-f, the peaks of 
release were delayed but the same amount was eventually 
released. In reported studies of bovine cartilage tissue, as 
the Fn-f concentration is decreased, a lag period occurs 
before damage is apparent and the period becomes longer 
as the concentration is decreased but the same amount of 
damage eventually occurs [2]. This may be due to a set 
time required for amplification of catabolic cytokines to a 
minimal threshold concentration required for initiation of 
damage. Another possibility is that the Fn-f must slowly 
concentrate in the matrix and reach a threshold tissue 
concentration before they are effective. 
The 29-kDa Fn-f has been shown to be more effective 
on cartilage tissue than the 140-kDa Fn-f [1] and was 
shown here to be more effective on induction of pro-Sin-1 
mRNA and protein in chondrocyte cultures as well. Since 
the interaction of the larger 140-kDa Fn-f with chondro- 
cytes in monolayer culture should not have been hampered 
as might occur with chondrocytes in cartilage tissue, the 
lesser activity of the 140-kDa Fn-f may be due to differ- 
ences in interaction with the chondrocyte cell surfaces. We 
do not yet know the mechanism for either Fn-f but we 
have proposed that the 140-kDa Fn-f may block the bind- 
ing of native cartilage Fn to its receptor and remove a 
stabilizing effect on signal transduction. The 29-kDa Fn-f 
may do so indirectly based on observations that amino- 
terminal Fn-f co-localize with alphasbeta ] integrins in 
focal adhesions [33] and amino-terminal Fn-f block bind- 
ing to the Fn receptor of antibodies to the alphasbeta ] Fn 
receptor [34]. 
Northern blot analysis showed that the pro-Sin-1 tran- 
scription was up-regulated in a fashion in which the peak 
of expression occurred earlier as the concentration of Fn-f 
was increased, as also shown with the protein data. With 
100 nM Fn-f, the maximum was at day 1, followed by a 
decline. This early and short term induction may be related 
to the observation that in cartilage tissue, cytokine expres- 
sion which induces pro-Sin-l, is also short term [14]. The 
delayed induction by 1 nM Fn-f is similar to the protein 
data and, as discussed above, may be due to the require- 
ment for a threshold accumulated concentration of cy- 
tokine or Fn-f. 
Gelatinase A mRNA was also enhanced, although the 
MMP protein induced to the highest levels was pro-Sin-1, 
based on metabolic labeling and SDS gel and Western blot 
analysis of the culture media. TIMP-1 mRNA was not 
induced, suggesting that the Fn-f do not induce a general 
up-regulation of mRNA synthesis and that TIMP-1 induc- 
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tion cannot counter the effects of induced MMPs in this 
system. Of the potential proteolytic activators tudied, the 
Fn-f only enhanced release of u-PA, although none of the 
activators appeared to activate pro-Sin-1. Preliminary data 
also suggest hat t-PA and u-PA mRNA levels are not 
elevated in Fn-f treated chondrocytes (Homandberg, un- 
published). Thus, at present we have no data to support he 
role of these activators in activation of pro-Sin-1 in this 
system. Nonetheless, these studies collectively show that 
the ability of Fn-f to enhance cartilage chondrolysis occurs 
through gene induction of MMPs. 
Acknowledgements 
This work was supported by the Arthritis Foundation, 
Greater Chicago Chapter and the National Institute of 
Arthritis, Musculoskeletal nd Skin Diseases SCOR Grant 
AR39239-03. 
References 
[1] Homandberg, G.A., Meyers, R. and Xie, D.L. (1992) J. Biol. Chem. 
267, 3597-3604. 
[2] Homandberg, G.A. and Hui, F. (1994) Arch. Biochem. Biophys 311, 
213-218. 
[3] Xie, D.L., Hui, F. and Homandberg, G.A. (1993) Arch. Biochem. 
Biophys. 307, 110-118. 
[4] Clemmensen, I. and Bach Andersen, R. (1982) Arthritis Rheum. 25, 
25-31. 
[5] Carsons, S., Lavietes, B.B., Diamond, H.S. and Kinney, S.G. (1985) 
Arthritis Rheum. 28, 601-612. 
[6] Dutu, A., Vlaicu-Rus, V., Bolosiu, H.D., Parasca, I. and Cristea, A. 
(1986) Med. Int. 24, 61-68. 
[7] Griffiths, A.M., Herbert, K.E., Perrett, D. and Scott, D.L. (1989) 
Clin. Chim. Acta 184, 133-146. 
[8] Xie, D.L., Meyers, R. and Homandberg, G.A. (1992) J. Rheumatol. 
19, 1448-1452. 
[9] Homandberg, G.A., Meyers, R. and Williams, J. (1993) J. Rheuma- 
tol. 20, 1378-1382. 
[10] Xie, D.L. and Homandberg, G.A. (1993) Biochim. Biophys. Acta 
1182, 189-196. 
[11] Homandberg, G.A. and Hui, F. (1994) Arch. Biochem. Biophys. 
310, 40-48. 
[12] Goldring, M.B., Birkhead, J., Sandell, L.J., Simura, T. and Krane, 
S.M. (1988). J. Clin. Invest. 82, 2026-2037. 
[13] Ito, A., Goshowaki, H., Sato, T., Moil, Y., Yamashita, K., Hayakawa, 
T. and Nagase, H. (1988) FEBS Lett. 234, 326-330. 
[14] Homandberg, G.A. and Hui, F. (1994) Trans. Orthop. Res. Soc. 19, 
464a. 
[15] Xie, D.L., Hui, F., Meyers, R. and Homandberg, G.A. (1994) Arch. 
Biochem. B iophys. 311,205-212. 
[16] Homandberg, G.A. and Erickson, J. (1986) Biochemistry 25, 6917- 
6925. 
[17] Kuettner, K.E., Memoli, V.A., Pauli, B.U., Wrobel, N.C., Thonar, 
E.J-M.A. and Daniel, J.C. (1982) J. Cell Biol. 93, 751-757. 
[18] Laemmli, U.K. (1970) Nature (London) 22, 680-685. 
[19] Chin, J., Murphy, G. and Werb, Z. (1985) J. Biol. Chem. 260, 
12367-12376. 
[20] Homandberg, G.A. and Wai, T. (1990) Biochim. Biophys. Acta 
1038, 209-215. 
[21] Chandrasekhar, A., Esterman, M.A. and Hoffman, H.A. (1987) 
Anal. Biochem. 161, 103-108. 
[22] Chomzynski, P. and Sacchhi, N. (1987) Anal. Biochem. 162, 156- 
159. 
[23] Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) in Molecular 
Cloning, A Laboratory Manual (Ford, N., Nolan, C., Ferguson, M., 
eds.), Second ed., sections 7.3-8.2., Cold Spring Harbor Laboratory 
Press, Cold Spring Harbor, New York. 
[24] Nagase, H., Enghild, J.J., Suzuki, K and Salveson, G. (1990) 
Biochemistry 29, 5783-5789. 
[25] Woessner, J.F, (1991) FASEB J. 5, 2145-2154. 
[26] Werb, Z., Mainardi, C.L., Vater, C.A. and Harris, E.D., Jr. (1977) 
N. Engl. J. Med. 296, 1017-1023. 
[27] Collier, S. and Ghosh, P. (1988) J. Rheumatol. 15, 1129-1137. 
[28] Mochan, E. and Uhl, J. (1984) J. Rheumatol. 11, 123-128. 
[29] Werb, Z. (1989) Proteinases and matrix degradation. In Textbook of 
Rheumatology (Kelly, W.N., Harris, E.D., Jr., Ruddy, S. and Sledge, 
C.B., eds.), 3rd ed., pp. 300-321, Saunders, Philadelphia. 
[30] Fini, M.T., Matsubara, M., Kublin, C., Tessier, M.T., Cintron, C. 
and Fini, M.E. (1993) J. Cell Sci. 104, 1001. 
[31] Levy, A.T., Cioce, V., Sobel, M.E., Garbisa, S., Grigioni, W.F., 
Liotta, L.A., Stetler-Stevenson, W.G. (1991) Cancer Res. 51, 439- 
444. 
[32] Gasson, J.C., Golde, D.W., Kaufman, S.E., Westbrrok, C.H., 
Hewick, R.M., Kaufman, R.J., Wang, G.G., Temple, P.A., Leary, 
A.C., Brown, E.L., Orr, E.C. and Clark, S.C. (1985) Nature 315, 
768-771. 
[33] Dzamba, B.J., Bultmann, H., Akiyama, S.K. and Peters, D.M. 
(1994) J. Biol. Chem. 269, 19646-19652. 
[34] Fogerty, F.J., Akiyama, S.K., Yamada, K.M. and Mosher, D.F. 
(1990) J. Cell. Biol. 111,699-708. 
